• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of October 17, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2163-12
Classification Class II
Code Info 6120184788, 6120182116, 6120180703, 6120180227, 6120179225, 6120178892, 6120177790, 6120177421, 6120176492, 6120175940, 6120171979, 6120170348, 6120169880, 6120168751, 6120168260, 6120167205, 6120166856, 6120165421, 6120164349, 6120164013, 6120162997, 6120162589, 6120161584, 6120161290, 6120160353, 6120155898, 6120154062, 6120152803, 6120152113, 6120151111, 6120150127. 6120149367, 6120148504, 6120147824, 6120147361, 6120146516, 6120139832, 6120139116, 6120137303, 6120136101, 6120134209, 6120133758, 6120133064, 6120131872, 6120131360, 6120130744, 6120139584, 6120129144, 6120128029, 6120127480, 6120126302, 6120125851, 6120125246, 6120124655, 6120124156, 6120123633, 6120123134, 6120122603, 6120121993, 6120121432, 6120120916, 6120119877
Product Distributed Qty 62 units
Reason For Recall Blood products, collected from a donor whose physical examination was incomplete, were distributed.

Event Detail

Event Id 49669
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc
City Columbia
State SC
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2007-07-10
Initial Firm Notification of Consignee or Public Other
Distribution Pattern IL, Switzerland & Germany
-
-